Urinary Catheters Not Needed for Joint Replacement Surgery
There is no increased risk for adverse genitourinary complications without the catheter
Urinary Tract Infection
USPSTF Urges Asymptomatic Bacteriuria Screening in Pregnancy
No net benefit seen for screening, treatment of asymptomatic bacteriuria for nonpregnant adults
Most UK Patients With UTI Receive Antibiotics on Same Day
Represcription rate at 28 days only 4.1% from 2011 to 2015; slight increase seen for men over time
Renal Anomaly on Fetal Scan May Up Risk for Admission for Child
Renal pelvis dilatation persisting in later pregnancy or after birth tied to increased risk for later admission
Recurrent Febrile UTI in Children Raises Renal Scarring Risk
Children who have a second febrile UTI had a nearly 12 times higher risk of renal scarring than those who have a single febrile UTI, according to investigators.
SGLT-2 Inhibitors Do Not Increase Risk for UTI in Type 2 Diabetes
Study finds no increased risks for severe or nonsevere urinary tract infections with SGLT-2 inhibitor use compared with other second-line antidiabetic drugs in type 2 diabetes patients.
FDA Approves Recarbrio for Complicated UTI, Abdominal Infections
The antibiotic Recarbrio is a combination of imipenem-cilastatin and relebactam.
Better UTI Monitoring Needed After Hospital Admission in Adults
Many healthcare-associated, community-onset urinary tract infections develop after being discharged.
Infections Tied to Subsequent Risk for Acute Ischemic Stroke
Correlation highest for UTI; smaller-magnitude associations seen for UTI with intracerebral hemorrhage
Investigational Oral Carbapenem Antibiotic Gets Fast-Tracked for cUTI, Acute Pyelonephritis
Spero Therapeutics announced that the Food and Drug Administration (FDA) has granted Fast Track designation for SPR994 (tebipenem pivoxil hydrobromide) for the treatment of complicated urinary tract infections (cUTI) and acute pyelonephritis (AP)
Next post in Urinary Tract Infections (UTI)
